RGRX — RegeneRx Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for RegeneRx Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.237	0.64	0.428	1.23	0.291
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.274	0.682	0.478	1.25	0.307
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.001	0.024	0.068	0.028	0.07
Other Long Term Assets
Total Assets	0.281	0.712	0.552	1.28	0.382
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.315	0.242	0.4	0.43	0.554
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.49	3.05	3.38	3.51	3.83
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.21	-2.34	-2.82	-2.23	-3.45
Total Liabilities & Shareholders' Equity	0.281	0.712	0.552	1.28	0.382
Total Common Shares Outstanding